Press "Enter" to skip to content

Study: Enzyme USP15 May Predict PARP Inhibitor Response in Breast, Pancreatic Cancers – Specialty Pharmacy Times

admin 0

Study: Enzyme USP15 May Predict PARP Inhibitor Response in Breast, Pancreatic Cancers  Specialty Pharmacy Times

The deubiquitylating enzyme USP15 may be a potential biomarker for therapeutic treatments using poly-(ADP-ribose) polymerase (PARP) inhibitors in cancers, …

“pancreatic cancer” – Google News

(Visited 5 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *